Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis

BACKGROUND: A number of studies have reported an association between the occurrence of immune-related adverse events (irAEs) and clinical efficacy in patients undergoing treatment with immune checkpoint inhibitors (ICIs), but the results remain controversial. METHODS: Under the guidance of a predefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiaoxiang, Yao, Zhuoran, Yang, Huaxia, Liang, Naixin, Zhang, Xuan, Zhang, Fengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169020/
https://www.ncbi.nlm.nih.gov/pubmed/32306958
http://dx.doi.org/10.1186/s12916-020-01549-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169020/
https://www.ncbi.nlm.nih.gov/pubmed/32306958
http://dx.doi.org/10.1186/s12916-020-01549-2

Ejemplares similares